Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
The Brighterside of News on MSN
New study finds 40Hz sensory stimulation may benefit some Alzheimer’s patients for years
A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...
Dr. Martínez-Lage shares Alzheimer's breakthroughs: why early diagnosis matters, the 4-step treatment plan for autonomy, and ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...
The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...
Ken Cohen, MD, FACP, discusses how new cognitive assessment tools are improving Alzheimer disease diagnosis.
Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...
The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...
Area residents are invited to lace up their shoes for the 2025 Walk to End Alzheimer’s — Wilmington on Saturday, Nov. 1. READ ...
1don MSN
40Hz sensory stimulation may benefit some Alzheimer's patients for years, small study suggests
A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback